INTRODUCTION

1
Trichosporon species are emerging fungal pathogens capable of causing localized or systemic 2 mycoses. Disseminated infection typically occurs in patients with underlying hematological 3 malignancy, organ transplantation and those otherwise heavily immunocompromised (5, 9, 18) . 4 Such infection is often lethal (mortality rates of 42-80%) (4, 13, 27). Furthermore, morbidity is 5 significant with multiple sequelae including respiratory and renal failure, and disseminated 6 intravascular coagulation (5, 9, 30, 35) . 7 With the advent of modern molecular identification techniques, the nomenclature within the 8 genus Trichosporon has been substantially revised. Whilst the major species previously 
cutaneum, T. dermatis, T. domesticum, T. faecale, T. inkin, T. japonicum, T. jirovecii, T. loubieri,
12
T. montevideense, and T. mucoides (5, 25 ). Yet the identification of Trichosporon and 13 closely-related yeasts to species level still largely relies on phenotypic-based methods which are 14 insensitive and time consuming (20) . Further, none of the available commercial phenotypic 15 identification systems include all new taxonomic categories, or species, in their databases. 16 Specifically, the API 20C AUX (bioMérieux, Marcy l'Etoile, France) as well as the Vitek 2 17 Compact YST (bioMérieux) systems are only able to identify three Trichosporon species: T. 18 asahii, T. inkin and T. mucoides, which may lead to erroneous species assignment (6, 11, 17, 23, 19 24). Species identification is important for epidemiological purposes and to better define 20 species-specific clinical associations (5, 11) . In addition, certain Trichosporon species may be 21 more resistant to antifungal drugs (2, 5, 25). 22 To enable accurate species identification, a number of molecular methods have been are the most frequently used (5, 7, 12, 19, 25, 26, (28) (29) (30) (31) . The IGS1 gene region has been 3 particularly useful in phylogenetic studies and in delineating intraspecies variation. These data 4 are fundamental to better understanding both species distribution and genotype differences that 5 have been reported according to geographic region, such as that observed with T. asahii (5, 12, 6 19, 26, 28, 29). 7 In contrast to data from South and North America and Japan, studies examining the species 8 distribution, phylogenetic diversity and antifungal susceptibilities of Trichosporon pathogens in 9 China are few. In the present study, we studied a collection of 45 clinical Trichosporon isolates 10 obtained from three hospitals in China along with three well-characterized reference strains. 
MATERIALS AND METHODS
17
Trichosporon strains and DNA extraction.
18
Forty-eight Trichosporon isolates were studied including (i) three reference strains namely T. 
RESULTS
10
Sequencing-based identification of Trichosporon species. Table S1. 14 The three loci correctly identified the reference strains to species level (Table 1,   15   Supplementary Table S1 ). Amongst 45 clinical isolates, six species were identified.
16
Trichosporon asahii was the most common species (35 isolates, 77.8%), followed by T. 18 dermatis and T. inkin (one isolate each, 2.2%) ( Table 1, Supplementary Table S1 ). Sequencing of 9 S1). mucoides), isolates in the present study were further subgrouped as 'species claimed by 7 databases' (37 isolates, two species) and 'species unclaimed by databases' (11 isolates, six 8 species) for analysis ( Table 2 ).
9
Compared with results obtained by our three-locus sequencing scheme, the API 20C AUX 10 system correctly identified 34 of 37 (91.9%) isolates amongst species claimed by databases, with 11 the remaining three isolates unidentified (with their biochemical profiles yielding either 'low 12 discrimination' or 'no identification') and no isolates misidentified; while amongst species 13 unclaimed by databases, four of 11 isolates were correctly shown as unidentified but seven were 14 misidentified (Tables 1 and 2 ). The ability of the Vitek 2 Compact YST system to identify 15 Trichosporon spp. amongst species claimed by databases was even lower -only 27 T. asahii 16 isolates (75.0% of 36 T. asahii isolates studied) were correctly identified; however, amongst 17 species unclaimed by databases, seven of 11 isolates were correctly shown as unidentified but 18 four isolates were misidentified (Tables 1 and 2) . Amongst the 48 isolates, the IGS1 region recognized 13 sequence types/genotypes (Table 3 ). Antifungal susceptibility testing. 15 The susceptibilities of 48 isolates representing eight species (based on the molecular 16 identification result) to five antifungal agents are shown in Table 1. MIC ranges (and geometric   17 mean [GM]) MICs were 0.125 to 32 µg/ml (1.09 µg/ml) for AMB, 1 to 16 µg/ml (9.15 µg/ml) for 18 CAS, 0.125 to 8 µg/ml (3.97 µg/ml) for FLC, 0.125 to 2 µg/ml (0.66 µg/ml) for ITC and 0.032 to 19 1 µg/ml (0.12 µg/ml) for VRC (Table 1) . CAS MICs for all Trichosporon isolates tested were 20 consistently high (>= 2 µg/ml for all strains tested except one T. asahii isolate CAS MIC = 1 21 µg/ml). Two T. japonicum isolates exhibited AMB MICs of >= 4 µg/ml, whilst all T. asahii 22 isolates had AMB MICs of <=1 µg/ml (GM MIC 0.91 µg/ml). With regard to the azoles, FLC 1 tested isolates and 3.67 µg/ml for the most common species T. asahii. ITC and VRC were the 2 most potent agents in vitro against all Trichosporon spp., particularly VRC, with GM MICs of 3 0.12 µg/ml. claimed to be included within their databases. We confirm that both ITS and IGS1 sequencing 13 are suitable targets for accurate species identification (with 100% sensitivity) (29, 30, this study).
14 Further, the IGS1 locus also provided discriminatory information with regard to strain variation 15 within the predominant species, T. asahii, encountered in China. 16 To date, the identification of Trichosporon yeasts in the clinical mycology laboratory has 17 largely relied on morphological, physiological and biochemical characteristics (20 
